Jubilant Cadista Clean Inspection

  Published 6 months ago

Jubilant Cadista’s September 19, 2025, inspection concluded with zero observations, highlighting top-quality compliance and excellence.

  • Jubilant Cadista operates under Jubilant Pharmova, the wholly owned subsidiary of the Jubilant Pharma group entity.
  • The inspection, completed on 19 September 2025, closed with no observations, confirming strict standards compliance.
  • Jubilant Pharmova globally provides radiopharmaceuticals, allergy immunotherapy, sterile injectables, CRDMO, generics, novel drugs, and services.

You might like these

Voltas Stock Dips Amid Rain Impact, Brokerage Cuts

SAMHI Hotels Reports Strong Q2 Surge

Trump Trade Policies Slow Global & US Growth

Eternal/Zomato Stock Surge: Brokerage Boost

Titan Intech Joins MIC for Mini-LED Tech

Ambuja Cements Shares Rise on Brokerage Upgrades

Meta's AI Talent Grab: New Superintelligence Labs Hiring Surge

News that matters the most ⚡